| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4050234 | ADME | Drug metabolism in human liver cytosol assessed as AOX-mediated 2-fluoro-N-methyl-4-(3-oxo-7-(quinolin-7-ylmethyl)-3,4-dihydroimidazo[1,2-b][1,2,4]triazin-2-yl)benzamide metabolite formation by measuring LC-MS peak area of the metabolite at 10 uM after 30 min by UPLC/Q-TOF MS analysis | Homo sapiens | 1 | ALA4049400 | assay format | Scientific Literature | |
| 2. | ALA4050239 | ADME | Drug metabolism in human liver cytosol assessed as AOX-mediated 2-fluoro-N-methyl-4-(3-oxo-7-(quinolin-7-ylmethyl)-3,4-dihydroimidazo[1,2-b][1,2,4]triazin-2-yl)benzamide metabolite formation by measuring LC-MS peak area of the metabolite at 10 uM after 30 mins in presence of menadione by UPLC/Q-TOF MS analysis | Homo sapiens | 1 | ALA4049400 | assay format | Scientific Literature | |
| 3. | ALA4050241 | Unassigned | Retention time of the compound by UPLC/Q-TOF MS analysis | 4 | ALA4049400 | assay format | Scientific Literature | ||
| 4. | ALA4050244 | ADME | Drug level in human liver cytosol treated with capmatinib assessed as AOX-mediated metabolite formation at 10 uM after 30 min by UPLC/Q-TOF MS analysis | Homo sapiens | 2 | ALA4049400 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!